Literature DB >> 26408342

Cocrystal habit engineering to improve drug dissolution and alter derived powder properties.

Dolores R Serrano1, Peter O'Connell1, Krzysztof J Paluch2, David Walsh1, Anne Marie Healy1.   

Abstract

OBJECTIVES: Cocrystallization of sulfadimidine (SDM) with suitable coformers, such as 4-aminosalicylic acid (4-ASA), combined with changes in the crystal habit can favourably alter its physicochemical properties. The aim of this work was to engineer SDM : 4-ASA cocrystals with different habits to investigate the effect on dissolution, and the derived powder properties of flow and compaction.
METHODS: Cocrystals were prepared in a 1 : 1 molar ratio by solvent evaporation using ethanol (habit I) or acetone (habit II), solvent evaporation followed by grinding (habit III) and spray drying (habit IV). KEY
FINDINGS: Powder X-ray diffraction showed Bragg peak position was the same in all the solid products. The peak intensity varied, indicating different preferred crystal orientation confirmed by SEM micrographs: large prismatic crystals (habit I), large plate-like crystals (habit II), small cube-like crystals (habit III) and microspheres (habit IV). The habit III exhibited the fasted dissolution rate; however, it underwent a polymorphic transition during dissolution. Habits I and IV exhibited the highest Carr's compressibility index, indicating poor flowability. However, habits II and III demonstrated improved flow. Spray drying resulted in cocrystals with improved compaction properties.
CONCLUSIONS: Even for cocrystals with poor pharmaceutical characteristics, a habit can be engineered to alter the dissolution, flowability and compaction behaviour.
© 2015 Royal Pharmaceutical Society.

Entities:  

Keywords:  cocrystal habit; dissolution; flowability; tabletability; wettability

Mesh:

Substances:

Year:  2015        PMID: 26408342     DOI: 10.1111/jphp.12476

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  4 in total

Review 1.  Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.

Authors:  Indumathi Sathisaran; Sameer Vishvanath Dalvi
Journal:  Pharmaceutics       Date:  2018-07-31       Impact factor: 6.321

2.  Development of Advanced 3D-Printed Solid Dosage Pediatric Formulations for HIV Treatment.

Authors:  Azizah M Malebari; Aytug Kara; Ahdab N Khayyat; Khadijah A Mohammad; Dolores R Serrano
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-31

3.  Impact of Crystal Habit on the Dissolution Rate and In Vivo Pharmacokinetics of Sorafenib Tosylate.

Authors:  Chi Uyen Phan; Jie Shen; Kaxi Yu; Jianming Mao; Guping Tang
Journal:  Molecules       Date:  2021-06-07       Impact factor: 4.411

4.  Engineering 3D Printed Microfluidic Chips for the Fabrication of Nanomedicines.

Authors:  Aytug Kara; Athina Vassiliadou; Baris Ongoren; William Keeble; Richard Hing; Aikaterini Lalatsa; Dolores R Serrano
Journal:  Pharmaceutics       Date:  2021-12-10       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.